Topics
July/August 2018 | Subfocus: Drug Delivery
Topical Drug Delivery for Retinal Disease Management
The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.
David S. Boyer, MD
June 12, 2026
Genetic Analysis Links Aspirin Use to Increased Risk of Early and Dry AMD
June 10, 2026
Ethyreal Bio Launches With $101 Million to Advance Potential Disease-Modifying Therapy for TED
AAO Partners with OpenEvidence to Bring Specialty Guidelines Directly Into AI Clinical Workflow
June 9, 2026
Optos Appoints Alexandre Montague as Chief Executive Officer
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
